• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于结构分析的可溶性K-Ras4B的表达、纯化及特性鉴定

Expression, purification, and characterization of soluble K-Ras4B for structural analysis.

作者信息

Abraham Sherwin J, Muhamed Ismaeel, Nolet Ryan, Yeung Fung, Gaponenko Vadim

机构信息

Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL 60607, United States.

出版信息

Protein Expr Purif. 2010 Oct;73(2):125-31. doi: 10.1016/j.pep.2010.05.015. Epub 2010 Jun 8.

DOI:10.1016/j.pep.2010.05.015
PMID:20566322
Abstract

A p21 GTPase K-Ras4B plays an important role in human cancer and represents an excellent target for cancer therapeutics. Currently, there are no drugs directly targeting K-Ras4B. In part, this is due to the lack of structural information describing unique features of K-Ras4B. Here we describe a methodology allowing production of soluble, well-folded K-Ras4B for structural analysis. The key points in K-Ras4B preparation are low temperature expression and extraction of K-Ras4B from the insoluble fraction using a nucleotide loading procedure in the presence of Mg(2+) and citrate, a low affinity chelator. Additionally, a significant amount of K-Ras4B could be extracted from the soluble fraction. We show that recombinant K-Ras4B is monomeric in solution. Excellent NMR signal dispersion suggests that the protein is well-folded and is amenable to solution structure determination. In addition, using phospholipid bilayer nanodiscs we show that recombinant K-Ras4B interacts with lipids and that this interaction is mediated by the C-terminal hypervariable region.

摘要

一种p21 GTP酶K-Ras4B在人类癌症中起重要作用,是癌症治疗的一个理想靶点。目前,尚无直接靶向K-Ras4B的药物。部分原因是缺乏描述K-Ras4B独特特征的结构信息。在此,我们描述了一种用于生产可溶、折叠良好的K-Ras4B以进行结构分析的方法。制备K-Ras4B的关键点是低温表达以及在存在低亲和力螯合剂Mg(2+)和柠檬酸盐的情况下,通过核苷酸加载程序从不溶性部分中提取K-Ras4B。此外,还可从可溶性部分中提取大量的K-Ras4B。我们证明重组K-Ras4B在溶液中为单体。出色的核磁共振信号分散表明该蛋白折叠良好,适合进行溶液结构测定。此外,使用磷脂双层纳米盘,我们证明重组K-Ras4B与脂质相互作用,且这种相互作用由C端高变区介导。

相似文献

1
Expression, purification, and characterization of soluble K-Ras4B for structural analysis.用于结构分析的可溶性K-Ras4B的表达、纯化及特性鉴定
Protein Expr Purif. 2010 Oct;73(2):125-31. doi: 10.1016/j.pep.2010.05.015. Epub 2010 Jun 8.
2
Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.致癌性和与RAS病相关的K-RAS突变可缓解效应器结合位点的膜依赖性封闭。
Proc Natl Acad Sci U S A. 2015 May 26;112(21):6625-30. doi: 10.1073/pnas.1419895112. Epub 2015 May 4.
3
The Hypervariable Region of K-Ras4B Governs Molecular Recognition and Function.K-Ras4B 的高变区决定分子识别和功能。
Int J Mol Sci. 2019 Nov 14;20(22):5718. doi: 10.3390/ijms20225718.
4
The hypervariable region of K-Ras4B is responsible for its specific interactions with calmodulin.K-Ras4B的高变区负责其与钙调蛋白的特异性相互作用。
Biochemistry. 2009 Aug 18;48(32):7575-83. doi: 10.1021/bi900769j.
5
Mechanisms of membrane binding of small GTPase K-Ras4B farnesylated hypervariable region.小GTP酶K-Ras4B法尼基化高变区的膜结合机制
J Biol Chem. 2015 Apr 10;290(15):9465-77. doi: 10.1074/jbc.M114.620724. Epub 2015 Feb 24.
6
Oncogenic K-Ras4B Dimerization Enhances Downstream Mitogen-activated Protein Kinase Signaling.致癌性 K-Ras4B 二聚化增强下游有丝分裂原激活的蛋白激酶信号转导。
J Mol Biol. 2020 Feb 14;432(4):1199-1215. doi: 10.1016/j.jmb.2020.01.002. Epub 2020 Jan 10.
7
K-Ras4B lipoprotein synthesis: biochemical characterization, functional properties, and dimer formation.
Protein Expr Purif. 2012 Jul;84(1):86-93. doi: 10.1016/j.pep.2012.04.021. Epub 2012 May 5.
8
Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction.钙调蛋白的柔性体运动和法尼基化高变区产生高亲和力相互作用,从而实现K-Ras4B的膜提取。
J Biol Chem. 2017 Jul 28;292(30):12544-12559. doi: 10.1074/jbc.M117.785063. Epub 2017 Jun 16.
9
GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site.GTP结合与致癌突变可能减弱小GTP酶K-Ras4B中高变区(HVR)-催化结构域的相互作用,从而暴露效应器结合位点。
J Biol Chem. 2015 Nov 27;290(48):28887-900. doi: 10.1074/jbc.M115.664755. Epub 2015 Oct 9.
10
The disordered hypervariable region and the folded catalytic domain of oncogenic K-Ras4B partner in phospholipid binding.致癌性K-Ras4B在磷脂结合中的无序高变区和折叠催化结构域。
Curr Opin Struct Biol. 2016 Feb;36:10-7. doi: 10.1016/j.sbi.2015.11.010. Epub 2015 Dec 20.

引用本文的文献

1
Pioneer in Molecular Biology: Conformational Ensembles in Molecular Recognition, Allostery, and Cell Function.分子生物学先驱:分子识别、别构效应及细胞功能中的构象集合体
J Mol Biol. 2025 Jun 1;437(11):169044. doi: 10.1016/j.jmb.2025.169044. Epub 2025 Feb 25.
2
Insight into structural dynamics involved in activation mechanism of full length KRAS wild type and P-loop mutants.深入了解全长KRAS野生型和P环突变体激活机制中涉及的结构动力学。
Heliyon. 2024 Aug 13;10(16):e36161. doi: 10.1016/j.heliyon.2024.e36161. eCollection 2024 Aug 30.
3
Intrinsically disordered proteins: Ensembles at the limits of Anfinsen's dogma.
内在无序蛋白质:处于安芬森法则极限的集合体。
Biophys Rev (Melville). 2022 Mar 17;3(1):011306. doi: 10.1063/5.0080512. eCollection 2022 Mar.
4
RAS-targeted cancer therapy: Advances in drugging specific mutations.RAS靶向癌症治疗:针对特定突变的药物研发进展
MedComm (2020). 2023 May 27;4(3):e285. doi: 10.1002/mco2.285. eCollection 2023 Jun.
5
Light at the end of the tunnel: Clinical features and therapeutic prospects of KRAS mutant subtypes in non-small-cell lung cancer.曙光在前:非小细胞肺癌中KRAS突变亚型的临床特征与治疗前景
Front Genet. 2022 Oct 21;13:890247. doi: 10.3389/fgene.2022.890247. eCollection 2022.
6
Pan-KRAS inhibitors suppress proliferation through feedback regulation in pancreatic ductal adenocarcinoma.泛 KRAS 抑制剂通过反馈调节抑制胰腺导管腺癌的增殖。
Acta Pharmacol Sin. 2022 Oct;43(10):2696-2708. doi: 10.1038/s41401-022-00897-4. Epub 2022 Mar 29.
7
Oncogenic KRAS: Signaling and Drug Resistance.致癌性KRAS:信号传导与耐药性。
Cancers (Basel). 2021 Nov 9;13(22):5599. doi: 10.3390/cancers13225599.
8
The current understanding of KRAS protein structure and dynamics.目前对KRAS蛋白结构与动力学的理解。
Comput Struct Biotechnol J. 2019 Dec 26;18:189-198. doi: 10.1016/j.csbj.2019.12.004. eCollection 2020.
9
An Application of pET SUMO Protein Expression System in Escherichia coli: Cloning, Expression, Purification, and Characterisation of Native Kras4B Oncoprotein.pET SUMO 蛋白表达系统在大肠杆菌中的应用:天然 Kras4B 癌蛋白的克隆、表达、纯化和特性分析。
Protein J. 2020 Feb;39(1):54-61. doi: 10.1007/s10930-019-09872-1.
10
The bacterial Ras/Rap1 site-specific endopeptidase RRSP cleaves Ras through an atypical mechanism to disrupt Ras-ERK signaling.细菌 Ras/Rap1 位点特异性内切酶 RRSP 通过一种非典型机制切割 Ras,从而破坏 Ras-ERK 信号转导。
Sci Signal. 2018 Oct 2;11(550):eaat8335. doi: 10.1126/scisignal.aat8335.